The rising tide of accidental overdoses linked to GLP-1 receptor agonists, with over 3,300 reports to the FDA, has prompted urgent action from health authorities. Stricter oversight of online and compounding pharmacies, alongside standardized dosing guidelines and targeted education programs, aims to address growing anxiety and distrust among racially and socioeconomically disadvantaged patients. If these issues remain unaddressed, they risk exacerbating health disparities and compromising safe access to vital therapies.